CRISPR perspectives: mechanisms, medicine and morals

Take stock of the CRISPR buzz at the FEBS Special Session on Science and Society, which includes a look at clinical applications and ethical concerns for CRISPR-based technologies.

As a quick, easy to use, cheap and reliable method of gene editing, CRISPR has taken biomedical research by storm ─ but its rapid and widespread adoption has led to concerns too, such as over its use in the germline. This Congress Special Session will take the audience from the science of CRISPR mechanisms, presented by one of the early microbiologist CRISPR pioneers, through promise and challenges of programmable nucleases in clinical applications, to considerations from a bioethics specialist of ethical and legal implications of recent developments in genome editing. The session is organized by the FEBS Science and Society Committee. Talk times are given in the Congress programme.

FEBS Special Session on Science and Societ− The role of CRISPR in Personalized Medicine: Legal and Ethical Problems (Wed Sep 13, 15.00−17.00)
Chair:  Emmanouil Fragkoulis, Athens, Greece
• CRISPR mechanism: RNA-guided DNA/RNA targeting, Francisco Mojica, Alicante, Spain
• Genome editing in the clinic: status, prospects and hurdles, Adi Barzel, Tel Aviv, Israel
• Genome editing, bioethics and the Oviedo Convention, Peter Mills, London, UK
• General discussion

FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. As a charitable academic organization, FEBS uses income from the journals to fund its diverse activities, including support for the FEBS Congress.